Prevention of graft-versus-host disease on an individual basis.
Aschan
J
J
Department of Clinical Immunology, Huddinge Hospital, Stockholm, Sweden.
Ringdén
O
O
Andström
E
E
Ljungman
P
P
Remberger
M
M
D016026:Bone Marrow Transplantation / Q000276:immunology*; D016572:Cyclosporine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D006086:Graft vs Host Disease / Q000453:epidemiology / Q000517:prevention & control*; D006680:HLA Antigens / Q000276:immunology; D006650:Histocompatibility Testing; D006801:Humans; D007938:Leukemia / Q000628:therapy; D008727:Methotrexate / Q000627:therapeutic use*; D012189:Retrospective Studies; D012307:Risk Factors
D006680:HLA Antigens; D016572:Cyclosporine; D008727:Methotrexate